Dare Bioscience risks Nasdaq delisting over market value
SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...
Acadia Realty Trust Launches $500 Million ATM Equity Offering
Acadia Realty Trust (NYSE:AKR), with a market capitalization of $2.98 billion, has announced an at-the-market equity offering program to sell common shares with a total value of up to $500 million.
The Province on MSN56m
Canucks ticket prices increase again. Can fans afford it?
Inflation has gone mad over the past few years, but not like that.